Jefferies Raises PT and Estimates on Gilead Sciences (GILD); Stribild (Quad Pill) Approved
Tweet Send to a Friend
Jefferies maintains a 'Hold' on Gilead Sciences (NASDAQ: GILD) price target of $55.00 (from $53.00).
Analyst, Thomas Wei, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Thomas Wei, said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
